Array Biopharma, Inc. (ARRY) Reports Q2 Loss of 17c/Share
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $6.97 -2.79%
Revenue Growth %: -12.3%
Financial Fact:
Net loss: -28.61M
Today's EPS Names:
CRMT, More
Revenue Growth %: -12.3%
Financial Fact:
Net loss: -28.61M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.17), $0.10 better than the analyst estimate of ($0.27).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Array Technologies (ARRY) PT Lowered to $10 at Jefferies, 'Playing Offense Amid Preferred Anxiety'
- General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
- MSC Industrial (MSM) Tops Q3 EPS by 17c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
